A University of Pennsylvania study has shown that bitter taste agonists stimulate the release of antimicrobial peptides in the sinuses, suggesting a new way to treat chronic rhinosinusitis. Although taste receptor-targeted therapies could decrease antibiotic use, pinpointing the right receptor for each infection might be difficult.